NephroCheck® Quality Test

Blood Purif. 2021;50(4-5):489-491. doi: 10.1159/000511727. Epub 2020 Dec 8.

Abstract

Background: The acute kidney injury (AKI) risk score helps detect moderate and severe AKI in the next 12-24 h. However, inappropriate urine collection may impact its results.

Aim: The aim of this study was to evaluate the stability of NephroCheck® after urine storage at different temperatures.

Methods: The urine sample was centrifuged and split into 3 tubes. One was tested as soon as possible by the laboratory. The other 2 samples were frozen at -20 and -80°C, and the NephroCheck® test was performed 8 weeks later.

Results: The mean values of the AKI risk score were 1.19 ± 0.93, 1.15 ± 1.14, and 1.20 ± 1.11 (ng/mL)2/1,000 for fresh urine, -20, and -80°C, respectively (p = 0.70). Spearman's rank correlation for -20 and -80°C versus immediate processing was strong with a rho of 0.82 and 0.98, respectively.

Conclusion: The AKI risk score was relatively stable. Urine could be collected without dry ice or liquid nitrogen and kept for up to 8 weeks with either -20 or -80°C freezing with stable NephroCheck® results.

Keywords: Acute kidney injury; Acute kidney injury risk score; Critical care; Insulin-like growth factor binding protein-7; Tissue inhibitor of metalloproteinases-2.

Publication types

  • Letter

MeSH terms

  • Acute Kidney Injury / diagnosis
  • Acute Kidney Injury / urine*
  • Biomarkers / urine
  • Cold Temperature
  • Humans
  • Insulin-Like Growth Factor Binding Proteins / urine
  • Tissue Inhibitor of Metalloproteinase-2 / urine
  • Urinalysis
  • Urine Specimen Collection

Substances

  • Biomarkers
  • Insulin-Like Growth Factor Binding Proteins
  • insulin-like growth factor binding protein-related protein 1
  • Tissue Inhibitor of Metalloproteinase-2